The Urokinase Receptor and its Structural Homologue C4.4A in Human Cancer: Expression, Prognosis and Pharmacological Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|25|2559-2573

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.25, 2008-10, pp. : 2559-2573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Relationship between Overexpression of Glial Cell-derived Neurotrophic Factor and Its RET Receptor with Progression and Prognosis of Human Pancreatic Cancer

By Zeng Q   Cheng Y   Zhu Q   Yu Z   Wu X   Huang K   Zhou M   Han S   Zhang Q  

The Journal of International Medical Research, Vol. 36, Iss. 4, 2008-07 ,pp. : 656-664

Field House Publishing

Access to resources Recommend Favorite

Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. : 1979-1983

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding

By Matsubara Y   Katoh S   Taniguchi H   Oka M   Kadota J   Kohno S  

The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. : 78-90

Field House Publishing

Access to resources Recommend Favorite

The Urokinase Receptor as a Potential Target in Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2359-2376

Bentham Science Publishers

Access to resources Recommend Favorite

Stable expression of the recombinant human VIP 1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties

By Gaudin P.   Couvineau A.   Maoret J.-J.   Rouyer-Fessard C.   Laburthe M.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 207-214

Elsevier

Access to resources Recommend Favorite